Fidelity Investments’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNY
TI
WCM
MCA
FFA
KCM
AAS
Fidelity Investments's MRNY Position: Q2 2026 in Review
Fidelity Investments opened a new position in YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026: 3 shares worth $58. The stake represents ﹤0.01% of the portfolio and ranks #5430 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in MRNY as recently as Q4 2025.
Fidelity Investments first reported a position in MRNY in Q4 2025 and has held it in 2 quarters since. The position peaked at $426 in Q4 2025. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.
- Fidelity Investments held 3 shares of YieldMax MRNA Option Income Strategy ETF worth $58 as of Q2 2026.
- YieldMax MRNA Option Income Strategy ETF was a new Fidelity Investments position in Q2 2026.
- YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5430 holding.
- Fidelity Investments first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2025 and has held it in 2 quarters since.
- Fidelity Investments's YieldMax MRNA Option Income Strategy ETF position peaked at $426 in Q4 2025.
- 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.